Exploring Glaucoma: From Pathogenesis to Emerging Diagnostic and Management Strategies
Glaucoma is a leading cause of irreversible blindness globally, affecting millions of individuals. It encompasses a group of progressive optic neuropathies characterized by retinal ganglion cell loss and visual field deterioration, often associated with elevated intraocular pressure.
Rajesh Kumar Goit, Nilufer Yesilirmak
wiley +1 more source
Introduction: Psychomotor performance task is used to assess the arousal and cognitive functions of the central nervous system. Alternatively, human visual working memory reflects the capability of the individual’s short-term memory.
Hayder M. Al-kuraishy, Ali I. Al-Gareeb
doaj
Interventions for preventing delirium in hospitalised non-ICU patients [PDF]
BACKGROUND: Delirium is a common mental disorder, which is distressing and has serious adverse outcomes in hospitalised patients. Prevention of delirium is desirable from the perspective of patients and carers, and healthcare providers.
Clegg, Andrew +6 more
core +2 more sources
Polytreatment in a very old patient. What’s better for safe prescribing?
Abstract Background Prescription for inappropriate drugs can be dangerous to very old people, due to the increased risk of adverse drug reactions. Case report We report the consequences of inappropriate prescriptions in a 99‐year‐old woman. She had a clinical history of vascular dementia, diabetes, hypothyroidism, heart failure, osteoarthritis, chronic
Pietro Gareri +3 more
wiley +1 more source
Neuroprotezione del paziente con glaucoma cronico ad angolo aperto:ruolo della Citicolina in soluzione orale [PDF]
Aim: To verify the efficacy of Citicoline, taken orally, in the prevention of neurological damage in patients with Chronic Open Angle Glaucoma (COA G). Methods: 30 subjects with COA G were divided into 2 groups: 18 subjects (CT group) were treated with ...
Badalamenti, R. +3 more
core
Edaravone's Safety Profile in Acute Ischemic Stroke
Participants: 64 enrolled, 58 completed edaravone treatment, 4 did not finish, 2 dropped out. Demographics: Majority male (n = 35), median age 53.5 years, 81.03% with moderate stroke severity. Findings: Two patients reported headaches, one reported dizziness; no serious adverse events documented.
Laurence K. J. Batino +2 more
wiley +1 more source
Изучение влияния комбинированного использования метилпреднизолона с цитиколином на процессы энергообеспечения митохондрий нейронов коры головного мозга и гистоморфометрические показатели его образований в условиях рассеянного склероза в эксперименте [PDF]
Study of combined use of methylprednisolone with citicoline to processes of energy providing of mitochondria to cortical neurons of the brain and histomorphometric indicators of its formation in the conditions of multiple sclerosis in the experiment ...
Мамчур, Виталий +2 more
core
Disorders of the immune status in patients with chronic cerebral ischemia; differentiated pharmacological correction [PDF]
The objective of the study is to establish the immune disorder patterns in patients with CCI I-II associated with arterial hypertension and to develop differentiated pharmacological methods for their ...
Bystrova, N. A. +2 more
core +2 more sources
This review addresses different types of biomaterials and their applications in treating nerve tissue injuries and neurodegenerative disorders. Moreover, it highlights several FDA‐approved biomaterial‐based products and ongoing clinical trials on biomaterials for nerve tissue regeneration.
Varsha Pai +2 more
wiley +1 more source
EFEK PEMBERIAN CITICOLINE TERHADAP STATUSRNFUNGSIONAL PASCACEDERA SARAF SCIATICUSRNPADA TIKUS PUTIH (RATTUS NORVEGICUS) [PDF]
Citicoline (CDP-choline) is an endogenous compound that serves as anintermediate compound in the synthesis of membrane phospholipids, acetylcholinesynthesis and as a metal donor. Citicoline can provide cholinergic andneuroprotective effects.
FAJRIAH
core

